Literature DB >> 19845833

Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure.

B Blairanne Williams1, Daphne Li, Michal Wegrzynowicz, Bhavin K Vadodaria, Joel G Anderson, Gunnar F Kwakye, Michael Aschner, Keith M Erikson, Aaron B Bowman.   

Abstract

Recognizing the similarities between Huntington's disease (HD) pathophysiology and the neurotoxicology of various metals, we hypothesized that they may exhibit disease-toxicant interactions revealing cellular pathways underlying neurodegeneration. Here, we utilize metals and the STHdh mouse striatal cell line model of HD to perform a gene-environment interaction screen. We report that striatal cells expressing mutant Huntingtin exhibit elevated sensitivity to cadmium toxicity and resistance to manganese toxicity. This neuroprotective gene-environment interaction with manganese is highly specific, as it does not occur with iron, copper, zinc, cobalt, cadmium, lead, or nickel ions. Analysis of the Akt cell stress signaling pathway showed diminished activation with manganese exposure and elevated activation after cadmium exposure in the mutant cells. Direct examination of intracellular manganese levels found that mutant cells have a significant impairment in manganese accumulation. Furthermore, YAC128Q mice, a HD model, showed decreased total striatal manganese levels following manganese exposure relative to wild-type mice. Thus, this disease-toxicant interaction screen has revealed that expression of mutant Huntingtin results in heightened sensitivity to cadmium neurotoxicity and a selective impairment of manganese accumulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845833      PMCID: PMC3083829          DOI: 10.1111/j.1471-4159.2009.06445.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  41 in total

1.  Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.

Authors:  Zhengkuan Mao; Yeun Su Choo; Mathieu Lesort
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

2.  Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells.

Authors:  Jae-Hoon Bae; Byeong-Churl Jang; Seong-Il Suh; Eunyoung Ha; Hyung Hwan Baik; Sung-Soo Kim; Mi-young Lee; Dong-Hoon Shin
Journal:  Neurosci Lett       Date:  2006-01-18       Impact factor: 3.046

3.  Alteration of iron homeostasis following chronic exposure to manganese in rats.

Authors:  W Zheng; Q Zhao; V Slavkovich; M Aschner; J H Graziano
Journal:  Brain Res       Date:  1999-06-26       Impact factor: 3.252

Review 4.  Iron, brain ageing and neurodegenerative disorders.

Authors:  Luigi Zecca; Moussa B H Youdim; Peter Riederer; James R Connor; Robert R Crichton
Journal:  Nat Rev Neurosci       Date:  2004-11       Impact factor: 34.870

Review 5.  Manganese dosimetry: species differences and implications for neurotoxicity.

Authors:  Michael Aschner; Keith M Erikson; David C Dorman
Journal:  Crit Rev Toxicol       Date:  2005-01       Impact factor: 5.635

6.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.

Authors:  M F Beal; E Brouillet; B G Jenkins; R J Ferrante; N W Kowall; J M Miller; E Storey; R Srivastava; B R Rosen; B T Hyman
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

7.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

8.  Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.

Authors:  Qingmin Ruan; Mathieu Lesort; Marcy E MacDonald; Gail V W Johnson
Journal:  Hum Mol Genet       Date:  2004-02-12       Impact factor: 6.150

9.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Authors:  D T Dexter; A Carayon; F Javoy-Agid; Y Agid; F R Wells; S E Daniel; A J Lees; P Jenner; C D Marsden
Journal:  Brain       Date:  1991-08       Impact factor: 13.501

10.  Generation and characterization of embryonic striatal conditionally immortalized ST14A cells.

Authors:  E Cattaneo; L Conti
Journal:  J Neurosci Res       Date:  1998-07-15       Impact factor: 4.164

View more
  35 in total

Review 1.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

2.  Role of Caenorhabditis elegans AKT-1/2 and SGK-1 in Manganese Toxicity.

Authors:  Tanara V Peres; Leticia P Arantes; Mahfuzur R Miah; Julia Bornhorst; Tanja Schwerdtle; Aaron B Bowman; Rodrigo B Leal; Michael Aschner
Journal:  Neurotox Res       Date:  2018-06-07       Impact factor: 3.911

3.  Manganese-induced Mitochondrial Dysfunction Is Not Detectable at Exposures Below the Acute Cytotoxic Threshold in Neuronal Cell Types.

Authors:  Emily B Warren; Miles R Bryan; Patricia Morcillo; Keisha N Hardeman; Michael Aschner; Aaron B Bowman
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.849

4.  Considerations on manganese (Mn) treatments for in vitro studies.

Authors:  Aaron B Bowman; Michael Aschner
Journal:  Neurotoxicology       Date:  2014-02-05       Impact factor: 4.294

5.  PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Bingying Han; Kevin C Ess; Charles C Hong; Keith M Erikson; Peter Hedera; Aaron B Bowman
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

6.  Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice.

Authors:  Anna C Pfalzer; Jordyn M Wilcox; Simona G Codreanu; Melissa Totten; Terry J V Bichell; Timothy Halbesma; Preethi Umashanker; Kevin L Yang; Nancy L Parmalee; Stacy D Sherrod; Keith M Erikson; Fiona E Harrison; John A McLean; Michael Aschner; Aaron B Bowman
Journal:  Metallomics       Date:  2020-07-22       Impact factor: 4.526

7.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

8.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

9.  Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.

Authors:  Piyush Joshi; Caroline Bodnya; Ilyana Ilieva; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2019-09-20       Impact factor: 4.294

10.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.